Press release
Primary Ovarian Insufficiency Market Size Forecasted To Achieve 1.73 Billion By 2029 With Steady Growth
Primary Ovarian Insufficiency Market
What Is the Primary Ovarian Insufficiency Market Size and Projected Growth Rate?
The market size for primary ovarian insufficiency has seen a swift expansion in the past few years. The market size, which was $1.07 billion in 2024, is projected to reach $1.18 billion in 2025, at a compound annual growth rate (CAGR) of 10.1%. The growth recorded in the recent past can be linked to factors like the escalating incidences of autoimmune diseases, heightened stress levels, growing number of genetic mutations, an increase in women opting for delayed childbirth, and a rise in endocrine disorder occurrences.
Future years are projected to witness a swift expansion of the primary ovarian insufficiency market, with its predicted size reaching $1.73 billion in 2029 with a compound annual growth rate (CAGR) of 10.0%. This anticipated growth throughout the forecast period can be traced back to the rising adoption of assisted reproductive technologies, increased preference for fertility preservation alternatives, mounting emphasis on personalized medicine, and a growing attraction towards hormonal therapies as well as the escalating utilization of fertility preservation methods. The market forecast includes ongoing trends such as advancements in diagnostic technology, the incorporation of genetic testing, tech advancements in fertility preservation, breakthroughs in non-hormonal therapies, and the innovation of early detection biomarkers.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24387&type=smp
What Are the Major Segments in the Primary Ovarian Insufficiency Market?
The primary ovarian insufficiency market covered in this report is segmented -
1) By Type: Hormone Replacement Therapy (HRT), Calcium and Vitamin D Supplements, In Vitro Fertilization (IVF), Stem Cell Therapy, Other Types
2) By Diagnosis Method: Blood Tests, Ultrasound Imaging, Genetic Testing
3) By Application: Less Than 20 Years Old, 20 To 30 Years Old, 30 To 45 Years Old, 45 Years Old And Older
4) By End-Users: Hospitals And Clinics, Specialty Fertility Centers
Subsegments:
1) By Hormone Replacement Therapy: Estrogen Therapy, Estrogen-Progestin Therapy, Transdermal Patches, Vaginal Estrogen Products, Oral Hormone Therapy
2) By Calcium And Vitamin D Supplements: Calcium Carbonate, Calcium Citrate, Vitamin D2 (Ergocalciferol), Vitamin D3 (Cholecalciferol), Combined Calcium + Vitamin D Formulations
3) By In Vitro Fertilization: Conventional In Vitro Fertilization, Intracytoplasmic Sperm Injection (ICSI), Egg Donation In Vitro Fertilization, Embryo Freezing And Transfer, Preimplantation Genetic Testing (PGT)
4) By Stem Cell Therapy: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Mesenchymal Stem Cell (MSC) Therapy, Ovarian Stem Cell Transplantation
5) By Other Types: Psychological Counseling And Support Therapies, Assisted Reproductive Technologies (other than IVF), Immunomodulatory Therapies, Lifestyle And Dietary Interventions
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24387&type=smp
What Are The Driving Primary Ovarian Insufficiency Market Evolution?
The rise in autoimmune disorders is anticipated to fuel the expansion of the primary ovarian insufficiency market. Autoimmune disorders are diseases in which the body's immune system erroneously attacks and destroys its own healthy cells and tissues. This surge in autoimmune disorders is primarily attributed to genetic predisposition, where certain inherited genes increase vulnerability to immune system malfunctions. Primary ovarian insufficiency (POI) contributes to a deeper comprehension of autoimmune disorders by illustrating how hormonal imbalance and immune system dysregulation interplay, raising the chances of autoimmune diseases in the affected population. For example, Versorgungsatlas.de, a German organization, stated in November 2024, that in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease. This accounted for a crude prevalence rate of 8.61%. Consequently, the escalating prevalence of autoimmune disorders is propelling the growth of the primary ovarian insufficiency market.
Which Firms Dominate The Primary Ovarian Insufficiency Market Segments?
Major companies operating in the primary ovarian insufficiency market are Mayo Clinic, Johns Hopkins Medicine, Baptist Health, Ferring Pharmaceuticals A/S, The Kingsley Natural Health Clinic, PreventionGenetics LLC, The Fertility Partnership (TFP) UK, Celmatix Inc., European Society of Human Reproduction and Embryology (ESHRE), Endocrine Society, IVIRMA Global, American Society for Reproductive Medicine (ASRM), TCM Healthcare (UK) Ltd., Bioscience Institute S.p.A., Sparsh Diagnostics Pvt. Ltd., Welling Homeopathy Clinics Pvt. Ltd., Bristol Menopause Clinic, Indira IVF Hospital Private Limited, Lawley Pharmaceuticals Pty. Ltd., OvaScience Inc.
What Are the Major Trends Shaping the Primary Ovarian Insufficiency Market?
The key players in the market for primary ovarian insufficiency are focusing on the development of innovative treatments like allogenic exosomal therapy to improve fertility and restore ovarian functionality. This therapy utilizes exosomes - extracellular vesicles which are derived from stem cells of a donor - to send signals for regeneration that promote tissue repair and reinstate ovarian functionality for patients afflicted with primary ovarian insufficiency. As an example, in October 2022, the FDA gave the green light to Vitti Labs LLC, a biotech company from the US, for the deployment of EV-Pure to treat primary ovarian insufficiency. This leverages the anti-inflammatory, regenerative, and immunomodulatory attributes of exosomes derived from mesenchymal stromal cells to reestablish fertility and ovarian functionality. This is a ready-to-use, cell-free therapy that negates the risks often associated with cell-based treatments, such as immune rejection or malignant transformation, and simultaneously delivers bioactive molecules geared towards promoting tissue repair and homeostasis.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/primary-ovarian-insufficiency-global-market-report
Which Is The Largest Region In The Primary Ovarian Insufficiency Market?
North America was the largest region in the primary ovarian insufficiency market in 2024. The regions covered in the primary ovarian insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Primary Ovarian Insufficiency Market?
2. What is the CAGR expected in the Primary Ovarian Insufficiency Market?
3. What Are the Key Innovations Transforming the Primary Ovarian Insufficiency Industry?
4. Which Region Is Leading the Primary Ovarian Insufficiency Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Ovarian Insufficiency Market Size Forecasted To Achieve 1.73 Billion By 2029 With Steady Growth here
News-ID: 4060924 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Primary
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market
Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics
The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031.
Primary Biliary Cholangitis (PBC), formerly known as…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
